Purple Biotech Ltd ADR (PPBT) concluded trading on Thursday at a closing price of $2.62, with 4.48 million shares of worth about $11.75 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -24.28% during that period and on July 24, 2025 the price saw a loss of about -4.73%. Currently the company’s common shares owned by public are about 2.84M shares, out of which, 2.84M shares are available for trading.
Stock saw a price change of 3.56% in past 5 days and over the past one month there was a price change of 12.93%. Year-to-date (YTD), PPBT shares are showing a performance of -62.68% which decreased to -44.14% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.00 but also hit the highest price of $13.95 during that period. The average intraday trading volume for Purple Biotech Ltd ADR shares is 110.05K. The stock is currently trading 4.71% above its 20-day simple moving average (SMA20), while that difference is up 6.08% for SMA50 and it goes to -15.12% lower than SMA200.
Purple Biotech Ltd ADR (NASDAQ: PPBT) currently have 2.84M outstanding shares and institutions hold larger chunk of about 1.94% of that.
The stock has a current market capitalization of $7.44M and its 3Y-monthly beta is at 0.51. It has posted earnings per share of -$2.45 in the same period. It has Quick Ratio of 2.72 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PPBT, volatility over the week remained 8.19% while standing at 5.80% over the month.
Stock’s fiscal year EPS is expected to rise by 76.75% while it is estimated to increase by 46.55% in next year. EPS is likely to grow at an annualized rate of 50.64% for next 5-years, compared to annual growth of 45.90% made by the stock over the past 5-years.
